Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
AssigneeGenzyme Corporation
InventorsOxana Ibraghimov-Beskrovnaya, Thomas A. Natoli
Life of this patent
Estimating the term…
Abstract
A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor.
Claims22
A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject, comprising administering to the subject an effective amount of a glucosylceramide synthase inhibitor.
Dependencies are inferred from the claim text.